Acne & Hair Loss
Buy acne and hair loss research compounds in Canada. Finasteride, Dutasteride, Minoxidil, Isotretinoin (Accutane), RU58841, Ketoconazole and more, shipped domestically from within Canada. Every compound is third party tested with a certificate of analysis on file. The most complete androgenic side effect management catalogue available from a domestic Canadian supplier.
Canada's most trusted domestic source for acne and hair loss research compounds. DHT inhibitors, topical anti androgens, retinoids, and minoxidil formulations. All sourced, tested, and dispatched same day from within Canada with no customs and no cross border delays.
Explore related categories
Acne & Hair Loss Compounds in Canada | DHT Inhibitors, Retinoids & Topical Anti-Androgens
Androgenic acne and androgenic alopecia (male pattern hair loss) are among the most commonly researched side effects in anabolic steroid research contexts. Both driven primarily by dihydrotestosterone (DHT) and DHT like androgens acting on sebaceous glands and androgen sensitive hair follicles respectively. Canada Steroid Depot stocks the complete range of compounds used to manage both conditions; from systemic DHT inhibitors and topical anti-androgens for hair loss, to oral retinoids and topical treatments for acne. Independently tested and shipped domestically from within Canada.
DHT inhibitors | Finasteride and Dutasteride
Finasteride and Dutasteride are 5-alpha reductase inhibitors (5-ARIs) that block the conversion of testosterone to dihydrotestosterone (DHT). The primary androgen responsible for androgenic alopecia and sebaceous gland overstimulation. Finasteride selectively inhibits the Type II isoform of 5-alpha reductase, reducing serum DHT by approximately 70%. Dutasteride inhibits both Type I and Type II isoforms, reducing serum DHT by up to 95%, making it significantly more potent than Finasteride for both hair loss and acne research applications. Both compounds are available as oral tablets. Dutasteride is increasingly researched as the preferred option in anabolic research contexts where DHT suppression needs to overcome the substantially elevated DHT produced by exogenous androgen administration.
Topical anti-androgens | RU58841 and CB-03-01
Topical anti-androgens block androgen receptors directly at the scalp without significantly impacting systemic DHT levels making them particularly valuable in anabolic research where systemic DHT suppression via oral 5-ARIs would also reduce the androgenic effects of the research compounds being studied. RU58841 is the most widely researched topical anti-androgen for androgenic alopecia, acting as a competitive androgen receptor antagonist at the hair follicle with minimal systemic absorption. CB-03-01 (Clascoterone) is a newer topical anti-androgen with both anti-androgenic and anti-sebaceous properties, researched for both hair loss and acne applications.
Isotretinoin (Accutane) for severe acne
Isotretinoin; most widely known by the brand name Accutane, is a synthetic retinoid and the most effective oral treatment for severe nodular acne currently available. It works through multiple mechanisms: dramatically reducing sebaceous gland size and sebum production, normalizing follicular keratinization, reducing Cutibacterium acnes colonization, and exerting anti-inflammatory effects. In anabolic research contexts, isotretinoin is researched for acne that is refractory to topical treatments and antibiotics. Particularly the severe cystic acne that can be exacerbated by androgenic compounds. CSD stocks pharmaceutical grade Isotretinoin capsules in multiple dose configurations.
Minoxidil for hair loss
Minoxidil is a potassium channel opener originally developed as an antihypertensive that was found to stimulate hair growth as a side effect. It is now the most widely researched topical treatment for androgenic alopecia, available in 2% and 5% topical solution and foam formulations, as well as low dose oral Minoxidil which has gained significant research interest in recent years for its systemic hair growth effects at doses of 0.25–2.5mg per day. Minoxidil is believed to work by prolonging the anagen (growth) phase of the hair cycle and increasing blood flow to hair follicles. It is commonly researched in combination with DHT inhibitors and topical anti-androgens for synergistic hair loss management.
Frequently asked questions
CSD stocks Finasteride, Dutasteride, RU58841, CB-03-01, Isotretinoin (Accutane), Minoxidil (topical and oral), Ketoconazole shampoo, and Spironolactone among others. Check the category page for current availability and stock status.
Finasteride inhibits only the Type II isoform of 5-alpha reductase, reducing serum DHT by approximately 70%. Dutasteride inhibits both Type I and Type II isoforms, reducing serum DHT by up to 95%. Dutasteride is significantly more potent and is increasingly preferred in research contexts. Particularly where elevated androgens from exogenous compounds make partial DHT suppression insufficient for hair loss or acne management.
RU58841 is a topical non steroidal anti-androgen that competitively blocks androgen receptors at the hair follicle level. Unlike oral DHT inhibitors, RU58841 acts locally at the scalp with minimal systemic absorption. Meaning it does not reduce circulating DHT or interfere with the systemic androgenic effects of research compounds. It is typically prepared as a 5% solution in ethanol or propylene glycol and applied directly to the scalp.
Isotretinoin reduces sebaceous gland size by up to 90% and sebum production by up to 80%, while simultaneously normalizing follicular keratinization and reducing bacterial colonization. In anabolic research contexts where elevated androgens drive severe sebaceous gland stimulation, isotretinoin addresses the downstream effects at the gland level rather than the androgen level. Making it effective even when androgenic compounds are continued.
Yes! Minoxidil and Finasteride (or Dutasteride) are the most commonly combined hair loss research protocol, addressing hair loss through complementary mechanisms. Minoxidil prolongs the anagen growth phase and increases follicular blood flow, while Finasteride/Dutasteride reduces DHT mediated follicular miniaturization. Adding a topical anti-androgen such as RU58841 creates a three pronged approach addressing the androgenic, growth cycle, and blood flow components simultaneously.
All orders ship from within Canada via tracked Canada Post or courier. Packages are plain and discreet with no identifying product information on the exterior. Most orders arrive within 2–5 business days depending on your province. Express shipping is available at checkout. Orders over $250 qualify for free shipping Canada wide.